Form 4: Definitive Healthcare Director Kathleen Winters Granted Over 55,000 Restricted Stock Units

Definitive Healthcare Corp. Director Kathleen A. Winters was granted 55,911 restricted stock units, increasing her direct beneficial ownership to 119,792 shares.

Summary

• Kathleen A. Winters, a Director of Definitive Healthcare Corp. (DH), acquired 55,911 shares of Class A Common Stock on June 5, 2025.
• These shares were acquired as Restricted Stock Units (RSUs) at a price of $0 per share, indicating a grant as part of compensation.
• Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• The RSUs are scheduled to vest on the earlier of June 5, 2026, or the date of the Issuer's next annual meeting of stockholders, contingent upon Ms. Winters' continued service.
• Following this transaction, Ms. Winters directly beneficially owns a total of 119,792 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the RSU grant aligns the director's interests with shareholders and serves as a retention mechanism, which is generally viewed favorably. However, it's a routine compensation event and not indicative of significant operational or financial news.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This RSU grant serves as a retention mechanism, incentivizing the director's continued service through the vesting period.

Future Outlook

The vesting schedule for the granted Restricted Stock Units indicates a future milestone for the director's compensation, contingent on continued service through June 5, 2026, or the next annual meeting of stockholders.

Industry Context

This Form 4 filing details a routine insider transaction, specifically an equity grant to a director, which is a common practice across industries for executive and board compensation to align interests and incentivize long-term commitment.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to directors is a standard compensation practice in publicly traded companies, including those in the healthcare technology and data analytics sectors like Definitive Healthcare Corp.
• RSUs are widely used as they provide a strong incentive for long-term value creation and retention, aligning director interests with shareholder returns, similar to practices observed at comparable companies such as Veeva Systems (VEEV) or IQVIA (IQV) in the healthcare data space.

Related Party Transactions

• Kathleen A. Winters, a Director of Definitive Healthcare Corp., received a grant of 55,911 Restricted Stock Units (RSUs) as part of her compensation, which is a transaction with a related party.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial interests with the company's stock performance, potentially benefiting shareholders through improved governance and long-term strategic focus.
• Employees: This transaction is part of standard compensation practices for leadership, which can positively influence employee morale by demonstrating commitment to executive retention and performance incentives.

Next Steps

• The 55,911 Restricted Stock Units are expected to vest on the earlier of June 5, 2026, or the date of Definitive Healthcare Corp.'s next annual meeting of stockholders, subject to Kathleen A. Winters' continued service.

Key Dates

Keywords

Definitive Healthcare, DH, Form 4, insider transaction, restricted stock units, RSU, beneficial ownership, director compensation, equity grant